title: Conservative treatment of early breast cancer.
abstract: At our Institution, the treatment policy for early carcinoma of the breast (T1-2, NO, AJC) is lumpectomy followed by radiotherapy to the breast and peripheral lymphatics. From October 1976 until December 1982, 171 patients have been admitted and treated. Radiotherapy was administered with 60 Co, 5.000 cGy in 5 weeks to the breast and lymphatics plus a boost to the scar giving q.s.p. 6.400 cGy at maximum tumor depth. With a minimum follow-up of 3 years and a median follow-up of 61.7 months the locoregional control was 94.2% and survival at 8 years with no evidence of disease (NED) was 77.2% with an overall survival rate of 90%. No difference in NED survival rate was found between Stage I and II. There was a tendency to better survival rate in those patients older than 50 years and also for post menopausal patients, however the difference did not reach statistical significance (66.7% NED survival at 8 years for premenopausal and 81.8% NED survival for post menopausal, also at 8 years, p = 0.056 Gehan). The time elapsed between surgery and radiation therapy (between 1 and 2 months) was found to be nonsignificant. Only 1 out of 171 patients had axillary dissection. The importance or lack of it, is discussed.
authors.affiliation: Instituto Radiomedicina IRAM, Santiago, Chile.
authors.forename: M R
authors.initials: MR
authors.lastname: Baeza
authors.forename: J
authors.initials: J
authors.lastname: Solé
authors.forename: A
authors.initials: A
authors.lastname: León
authors.forename: J
authors.initials: J
authors.lastname: Arraztoa
authors.forename: R
authors.initials: R
authors.lastname: Rodríguez
authors.forename: R
authors.initials: R
authors.lastname: Claure
authors.forename: S
authors.initials: S
authors.lastname: Cornejo
authors.forename: J
authors.initials: J
authors.lastname: Cornejo
mesh_terms: D001943:Breast Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008593:Menopause; D009367:Neoplasm Staging; D011878:Radiotherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage